EPCAM and endometrial cancer: CD44, transglutaminase 2 (TGM2), and epithelial cell adhesion molecule (EpCAM) were identified as novel plasma markers for endometrial cancer diagnosis using the MAGPIX® System, which employs magnetic nanoparticles coated with antibodies and requires a tiny sample volume (25 μL) [98].